Clinical Trial Update: Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating toripalimab and JS004 in combination with platinum-based chemotherapy for relapsed and extensive-stage small cell lung cancer is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• JS004 (JS004)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Small Cell Lung Cancer Extensive Stage, Small Cell Lung Cancer Recurrent | Phase 2 | Status: NOT_YET_RECRUITING